scholarly article | Q13442814 |
P50 | author | Carsten Geisler | Q41599581 |
Marina Rode von Essen | Q41599870 | ||
Peter Schjerling | Q41600446 | ||
Klaus Ølgaard | Q42529530 | ||
Martin Kongsbak | Q56884160 | ||
P2093 | author name string | Niels Odum | |
P2860 | cites work | T cell activation | Q24658051 |
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 | ||
DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 | Q28285583 | ||
LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway | Q28290956 | ||
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response | Q28298985 | ||
Tentative T cells: memory cells are quick to respond, but slow to divide | Q33327693 | ||
On the mechanism underlying (23S)-25-dehydro-1alpha(OH)-vitamin D3-26,23-lactone antagonism of hVDRwt gene activation and its switch to a superagonist | Q33508413 | ||
Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line | Q33606123 | ||
Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases | Q34398421 | ||
Regulation of phospholipase C isozymes by ras superfamily GTPases | Q34482971 | ||
Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells | Q34563307 | ||
Jurkat T cells and development of the T-cell receptor signalling paradigm | Q35730832 | ||
1,25-Dihydroxyvitamin D3 upregulates the phosphatidylinositol signaling pathway in human keratinocytes by increasing phospholipase C levels | Q35751427 | ||
New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model | Q35868761 | ||
T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2 | Q36228047 | ||
Fc gamma receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-gamma 1 and PLC-gamma 2 in natural killer cells | Q36232058 | ||
Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro | Q36377398 | ||
The vitamin D receptor is required for iNKT cell development | Q36516149 | ||
The many paths to p38 mitogen-activated protein kinase activation in the immune system | Q36518938 | ||
Activation and differentiation requirements of primary T cells in vitro | Q36566049 | ||
Cloning of the human phospholipase C-gamma1 promoter and identification of a DR6-type vitamin D-responsive element | Q36847893 | ||
Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice | Q37081613 | ||
The biochemistry of somatic hypermutation | Q37096080 | ||
T cell receptor-mediated activation of p38{alpha} by mono-phosphorylation of the activation loop results in altered substrate specificity | Q37257277 | ||
Extracellular calcium-sensing receptor activation induces vitamin D receptor levels in proximal kidney HK-2G cells by a mechanism that requires phosphorylation of p38alpha MAPK. | Q40059362 | ||
A novel immunosuppressive 1alpha,25-dihydroxyvitamin D3 analog with reduced hypercalcemic activity | Q40683234 | ||
Localization of LAT in glycolipid-enriched microdomains is required for T cell activation | Q40925751 | ||
Functional analysis of LAT in TCR-mediated signaling pathways using a LAT-deficient Jurkat cell line | Q40949941 | ||
Enhanced responsiveness of human memory T cells to CD2 and CD3 receptor-mediated activation | Q41897072 | ||
CD3 antigen-mediated calcium signals and protein kinase C activation are higher in CD45R0+ than in CD45RA+ human T lymphocyte subsets | Q42509393 | ||
Characterization and expression of the human T cell receptor-T3 complex by monoclonal antibody F101.01. | Q43707203 | ||
In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice | Q43791658 | ||
The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibition | Q43976249 | ||
TCR down-regulation controls virus-specific CD8+ T cell responses | Q45388594 | ||
Immunomodulation by a novel, dissociated Vitamin D analogue | Q46110928 | ||
Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells | Q46681487 | ||
Two distinct pathways exist for down-regulation of the TCR. | Q47909827 | ||
CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. | Q52040001 | ||
Activation requirements for CD4+ T cells differing in CD45R expression | Q52071298 | ||
Differential activation requirements for virgin and memory T cells. | Q52120643 | ||
The effects of heavy resistance training and detraining on satellite cells in human skeletal muscles. | Q53892052 | ||
Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system | Q66829131 | ||
Measurement of 1,25-dihydroxyvitamin D3 receptor turnover by dense amino acid labeling: changes during receptor up-regulation by vitamin D metabolites | Q70161078 | ||
1,25-Dihydroxyvitamin D3Receptors in Human Leukocytes | Q70161320 | ||
Differential activation of phospholipase C-gamma 1 and mitogen-activated protein kinase in naive and antigen-primed CD4 T cells by the peptide/MHC ligand | Q71217146 | ||
Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin | Q72332647 | ||
TCR avidity: it's not how strong you make it, it's how you make it strong | Q74286634 | ||
Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR | Q74286685 | ||
Connections between growth and the cell cycle | Q77891934 | ||
Src homology 2 domain-containing leukocyte phosphoprotein of 76 kDa and phospholipase C gamma 1 are required for NF-kappa B activation and lipid raft recruitment of protein kinase C theta induced by T cell costimulation | Q78701794 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vitamin | Q34956 |
vitamin D | Q175621 | ||
P304 | page(s) | 344-9 | |
P577 | publication date | 2010-04-01 | |
P1433 | published in | Nature Immunology | Q1071725 |
P1476 | title | Vitamin D controls T cell antigen receptor signaling and activation of human T cells | |
P478 | volume | 11 |
Q36718044 | 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages |
Q64241054 | 1,25-Dihydroxyvitamin D3 Ameliorates Collagen-Induced Arthritis via Suppression of Th17 Cells Through miR-124 Mediated Inhibition of IL-6 Signaling |
Q82292920 | 1,25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells |
Q38111420 | 1,25-dihydroxyvitamin D in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. |
Q35933893 | 1α,25(OH)2 Vitamin D3 Modulates Avian T Lymphocyte Functions without Inducing CTL Unresponsiveness |
Q36316790 | 1α,25-dihydroxyvitamin D3 promotes CD200 expression by human peripheral and airway-resident T cells |
Q34076892 | 25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings |
Q35892921 | A comparative phase 1 clinical trial to identify anti-infective mechanisms of vitamin D in people with HIV infection |
Q34341819 | A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. |
Q28540144 | A stochastic chemical dynamic approach to correlate autoimmunity and optimal vitamin-D range |
Q36905046 | A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response |
Q39090564 | ASTHMA - comparing the impact of vitamin D versus UVR on clinical and immune parameters. |
Q41085196 | Activated human CD4+ T cells express transporters for both cysteine and cystine |
Q34517575 | Activity of 25-hydroxylase in human gingival fibroblasts and periodontal ligament cells |
Q38263409 | Amino acids and immune response: a role for cysteine, glutamine, phenylalanine, tryptophan and arginine in T-cell function and cancer? |
Q37535492 | Anti-Inflammatory Effects of Vitamin D on Human Immune Cells in the Context of Bacterial Infection |
Q37155258 | Association Between Vitamin D Deficiency and Allergic Diseases |
Q26823196 | Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis |
Q40589672 | Association between vitamin D deficiency and pre-existing resistance-associated hepatitis C virus NS5A variants |
Q34994918 | Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study |
Q35809016 | Associations between Vitamin D Status, Supplementation, Outdoor Work and Risk of Parkinson's Disease: A Meta-Analysis Assessment |
Q37935877 | Asthma, allergy and respiratory infections: the vitamin D hypothesis |
Q33815649 | BCG vaccination: a role for vitamin D? |
Q35555589 | Bronchial asthma and hypovitaminosis D in Saudi children |
Q36353718 | Calcitriol modulates the CD46 pathway in T cells |
Q35154069 | Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings |
Q34326600 | Characterization of the autocrine/paracrine function of vitamin D in human gingival fibroblasts and periodontal ligament cells |
Q64286928 | Co-activation of macrophages and T cells contribute to chronic GVHD in human IL-6 transgenic humanised mouse model |
Q50607622 | Combined Single-Cell Measurement of Cytokine mRNA and Protein Identifies T Cells with Persistent Effector Function. |
Q36638670 | Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis |
Q82951636 | Control of T cell activation by vitamin D |
Q40146615 | Counter-intuitive plasma vitamin D and zinc status in HIV-1-infected adults with persistent low-level viraemia after treatment initiation: a pilot case-control study. |
Q37506724 | Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit |
Q41725092 | Cutaneous malignant melanoma incidences analyzed worldwide by sex, age, and skin type over personal Ultraviolet-B dose shows no role for sunburn but implies one for Vitamin D3. |
Q35168543 | Cutting edge: progesterone directly upregulates vitamin d receptor gene expression for efficient regulation of T cells by calcitriol |
Q34629145 | Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation |
Q36001269 | Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor |
Q36201635 | Dietary and commensal derived nutrients: shaping mucosal and systemic immunity. |
Q38046108 | Dietary influences on intestinal immunity |
Q36110205 | Does vitamin-D intake during resistance training improve the skeletal muscle hypertrophic and strength response in young and elderly men? - a randomized controlled trial |
Q34013557 | Early events governing memory CD8+ T-cell differentiation |
Q38288558 | Effect of 1,25(OH)2 D3 and 20(OH)D3 on interleukin-1β-stimulated interleukin-6 and -8 production by human gingival fibroblasts |
Q62489966 | Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial |
Q35130052 | Effect of vitamin D therapy on interleukin-6, visfatin, and hyaluronic acid levels in chronic hepatitis C Egyptian patients |
Q40049023 | Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-infected Youth |
Q37424371 | Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study |
Q36151999 | Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha |
Q36565937 | Ethanol and vitamin D receptor in T cell apoptosis |
Q58108351 | Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis |
Q28607343 | Exponentially increasing incidences of cutaneous malignant melanoma in Europe correlate with low personal annual UV doses and suggests 2 major risk factors |
Q45434695 | Fascinating interaction between host and pathogen |
Q39252599 | Fine tuning of vitamin D receptor (VDR) activity by post-transcriptional and post-translational modifications |
Q38906846 | Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease. |
Q35118388 | GADS is required for TCR-mediated calcium influx and cytokine release, but not cellular adhesion, in human T cells |
Q36004945 | Genes and life-style factors in BELFAST nonagenarians: Nature, Nurture and Narrative |
Q90358338 | Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C |
Q36309024 | Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study |
Q28069099 | Genome-Editing Technologies for Enhancing Plant Disease Resistance |
Q38202921 | Genomic binding sites and biological effects of the vitamin D--VDR complex in multiple sclerosis [corrected]. |
Q37637890 | High Expression of Antiviral and Vitamin D Pathway Genes Are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals |
Q34799320 | High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial |
Q38060570 | How important is vitamin D in preventing infections? |
Q37046776 | Immunogenomics reveal molecular circuits of diclofenac induced liver injury in mice |
Q48322815 | Immunological function of vitamin D during human pregnancy. |
Q49712080 | Impact of vitamin D receptor and binding protein gene polymorphisms in clinical and laboratory data of HCV patients: Cross sectional study |
Q34231027 | Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity |
Q40282583 | Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area. |
Q34481389 | Increased vitamin D is associated with decline of naïve, but accumulation of effector, CD8 T cells during early aging |
Q26830867 | Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE). |
Q30401858 | Influence of Rs2228570 on Transcriptional Activation by the Vitamin D Receptor in Human Gingival Fibroblasts and Periodontal Ligament Cells |
Q35749489 | Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients |
Q35797066 | Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes |
Q34123145 | Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? |
Q54346436 | Lack of association of vitamin D receptor gene 3'-haplotypes with psoriasis in Croatian patients. |
Q36079228 | Low serum vitamin-D status is associated with high prevalence and early onset of type-1 diabetes mellitus in Kuwaiti children |
Q33919832 | Low vitamin D in narcolepsy with cataplexy. |
Q44553568 | Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients |
Q55215318 | Lowered dietary phosphorus affects intestinal and renal gene expression to maintain mineral homeostasis with immunomodulatory implications in weaned piglets. |
Q21296718 | Mechanisms behind functional avidity maturation in T cells |
Q34790948 | Metabolic control of regulatory T cell development and function |
Q27011787 | Metabolic factors and chronic hepatitis C: a complex interplay |
Q37151353 | Metabolites: messengers between the microbiota and the immune system |
Q38317775 | Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes |
Q96304273 | Multiple Sclerosis: Lipids, Lymphocytes, and Vitamin D |
Q37772077 | Multiple sclerosis genetics--is the glass half full, or half empty? |
Q37623224 | Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MS. |
Q37599437 | Narrowband UVB Phototherapy for Clinically Isolated Syndrome: A Trial to Deliver the Benefits of Vitamin D and Other UVB-Induced Molecules |
Q60310655 | No Evidence for Lower Levels of Serum Vitamin D in the Presence of Hepatic Steatosis. A Study on the Portuguese General Population |
Q36225293 | No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults |
Q92082162 | Nutritional Modulation of Immune and Central Nervous System Homeostasis: The Role of Diet in Development of Neuroinflammation and Neurological Disease |
Q44271851 | PKC-θ exists in an oxidized inactive form in naive human T cells. |
Q64072217 | Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation |
Q40650428 | Pharmacogenetics of ribavirin-induced anemia in HCV patients |
Q33676554 | Phospholipase Cγ1 connects the cell membrane pathway to the nuclear receptor pathway in insect steroid hormone signaling. |
Q41887145 | Plant Innate Immunity Multicomponent Model |
Q35855391 | Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status. |
Q38716392 | Prevalence and clinical impact of vitamin D deficiency on abdominal tuberculosis |
Q35131051 | Probiotics, nuclear receptor signaling, and anti-inflammatory pathways |
Q42229887 | Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons |
Q34286493 | Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice |
Q26824042 | Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease |
Q53061723 | Regulation of CYP27B1 and CYP24A1 hydroxylases limits cell-autonomous activation of vitamin D in dendritic cells. |
Q35197174 | Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis |
Q46470367 | Report of the CCFA pediatric bone, growth and muscle health workshop, New York City, November 11-12, 2011, with updates |
Q48111413 | Revision of food-based dietary guidelines for Ireland, Phase 1: evaluation of Ireland's food guide |
Q42203898 | Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon. |
Q36293843 | Role of acid sphingomyelinase bioactivity in human CD4+ T-cell activation and immune responses |
Q34590575 | Role of autophagy in the host response to microbial infection and potential for therapy |
Q90198235 | Role of diet in regulating the gut microbiota and multiple sclerosis |
Q33752553 | Role of the microbiota in immunity and inflammation |
Q38610901 | Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer |
Q45350988 | Serum 25-hydroxyvitamin D predicts severity in Parkinson's disease patients |
Q36213642 | Signaling pathways in aged T cells - a reflection of T cell differentiation, cell senescence and host environment |
Q36225257 | Single-nucleotide polymorphism at CYP27B1-1260, but not VDR Taq I, is possibly associated with persistent hepatitis B virus infection |
Q33629800 | Spontaneous regression of metastatic cancer cells in the lymph node: a case report |
Q43054411 | T cell priming: let there be light |
Q34534123 | T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells |
Q38767662 | T-cell receptor-engineered T cells for cancer treatment: current status and future directions |
Q38672342 | The Active Metabolite of Vitamin D3 as a Potential Immunomodulator |
Q58789362 | The Impact of Vitamin D on the Immunopathophysiology, Disease Activity, and Extra-Musculoskeletal Manifestations of Systemic Lupus Erythematosus |
Q50560923 | The association of serum 25-OH vitamin D with atopy, asthma, and lung function in a prospective study of Danish adults. |
Q37806123 | The emerging role of vitamin D binding protein in multiple sclerosis |
Q21131158 | The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome |
Q35997084 | The impact of vitamin D deficiency on immune T cells in asthmatic children: a case-control study |
Q30388273 | The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells. |
Q40131972 | The role of vitamin D on circulating memory T cells in children: The Generation R study |
Q36935197 | The vitamin d receptor and T cell function |
Q37981255 | Translating the role of vitamin D3 in infectious diseases |
Q92282117 | Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response |
Q42233619 | Tumour necrosis factor-alpha, interleukin-10, interferon-gamma and vitamin D receptor gene polymorphisms in patients with chronic hepatitis delta |
Q50301196 | Untangling the most probable role for vitamin D3 in autism |
Q36685288 | VDR hypermethylation and HIV-induced T cell loss |
Q28081150 | Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease |
Q38723153 | Vitamin D Counteracts Mycobacterium tuberculosis-Induced Cathelicidin Downregulation in Dendritic Cells and Allows Th1 Differentiation and IFNγ Secretion |
Q64263827 | Vitamin D Deficiency in the Gulf Cooperation Council: Exploring the Triad of Genetic Predisposition, the Gut Microbiome and the Immune System |
Q38865481 | Vitamin D Potentiates the Inhibitory Effect of MicroRNA-130a in Hepatitis C Virus Replication Independent of Type I Interferon Signaling Pathway. |
Q36935388 | Vitamin D Supplementation Modulates T Cell-Mediated Immunity in Humans: Results from a Randomized Control Trial |
Q47171978 | Vitamin D and Neurological Diseases: An Endocrine View |
Q26784321 | Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin |
Q37762187 | Vitamin D and health status in elderly |
Q37919185 | Vitamin D and immune function: an overview |
Q33806322 | Vitamin D and inflammatory diseases |
Q34204170 | Vitamin D and mucosal immune function |
Q38090585 | Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? |
Q44252883 | Vitamin D and respiratory infection in adults |
Q52586105 | Vitamin D and the Liver-Correlation or Cause? |
Q33569349 | Vitamin D and the epigenome. |
Q92798751 | Vitamin D as a Principal Factor in Mediating Rheumatoid Arthritis-Derived Immune Response |
Q98564199 | Vitamin D can be effective on the prevention of COVID-19 complications: A narrative review on molecular aspects |
Q35920711 | Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. |
Q34728285 | Vitamin D deficiency in chronic liver disease. |
Q41543377 | Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury |
Q42218324 | Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. |
Q35135697 | Vitamin D depletion aggravates hypertension and target-organ damage |
Q28081172 | Vitamin D every day to keep the infection away? |
Q34550631 | Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. |
Q35594278 | Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study |
Q38080943 | Vitamin D in chronic liver disease |
Q38611147 | Vitamin D in rheumatoid arthritis-towards clinical application |
Q33648411 | Vitamin D increases programmed death receptor-1 expression in Crohn's disease |
Q37518789 | Vitamin D insufficiency may impair CD4 recovery among Women's Interagency HIV Study participants with advanced disease on HAART. |
Q37492503 | Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals |
Q33828491 | Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatment |
Q37918438 | Vitamin D metabolism and signaling in the immune system |
Q36308961 | Vitamin D receptor activation and downregulation of renin-angiotensin system attenuate morphine-induced T cell apoptosis. |
Q26782833 | Vitamin D receptor and epigenetics in HIV infection and drug abuse |
Q41699389 | Vitamin D receptor signals regulate effector and memory CD8 T cell responses to infections in mice |
Q49985993 | Vitamin D receptor: A novel therapeutic target for kidney diseases |
Q42283903 | Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection |
Q38878795 | Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats. |
Q35162343 | Vitamin D up-regulates the vitamin D receptor by protecting it from proteasomal degradation in human CD4+ T cells |
Q91728168 | Vitamin D, Autoimmune Disease and Rheumatoid Arthritis |
Q37825379 | Vitamin D, UV, and skin cancer in the elderly: to expose or not to expose? |
Q35187318 | Vitamin D, allergies and asthma: focus on pediatric patients |
Q38043397 | Vitamin D, immune tolerance, and prevention of type 1 diabetes |
Q95728328 | Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study |
Q35259198 | Vitamin D-binding protein controls T cell responses to vitamin D. |
Q33568222 | Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients |
Q91610516 | Vitamin D/Vitamin D Receptor Signaling Is Required for Normal Development and Function of Group 3 Innate Lymphoid Cells in the Gut |
Q52687545 | Vitamin D3 Supplementation Reduces Subsequent Brain Injury and Inflammation Associated with Ischemic Stroke. |
Q34117516 | Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis |
Q37927252 | Vitamin D3: a helpful immuno-modulator |
Q44132017 | Vitamin D: emerging roles in infection and immunity |
Q33781589 | Vitamin D: relevance in dental practice |
Q35146600 | Vitamin d deficiency in a multiethnic healthy control cohort and altered immune response in vitamin D deficient European-American healthy controls |
Q38857718 | Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study |
Q37214454 | Worldwide cutaneous malignant melanoma incidences analyzed by sex, age, and skin type over time (1955-2007): Is HPV infection of androgenic hair follicular melanocytes a risk factor for developing melanoma exclusively in people of European-ancestry? |
Q84542800 | [Vitamin D metabolism] |
Q38562587 | mTOR and its tight regulation for iNKT cell development and effector function |
Search more.